J&J has not released data about how its vaccine fights variant
I am a vet and I received my COVID vaccine, Johnson & Johnson, from the White City VA. I was given a choice of all three vaccines; I chose the J&J. Why do we not hear anything about the J&J when the media talks about vaccines and the Delta variant? Is the J&J as good as the other two, and is it as effective against the Delta variant?
— Jim B., Medford
Johnson & Johnson has not released data about how its vaccine fares against the Delta variant, Jim, but studies are being conducted.
According to a study from Public Health England from late May, the AstraZeneca vaccine, which is similarly effective to Johnson & Johnson’s vaccine, was 60% effective against the Delta variant. It was 6% less effective against the Alpha variant.
The same study showed that the Pfizer-BioNTech vaccine was 88% effective against the Delta variant. It was 5% less effective against the Alpha variant.
Given this, it is unlikely that the Johnson & Johnson vaccine will be as effective against the Delta variant as Pfizer-BioNTech or Moderna, which has performed similarly to the Pfizer vaccine.
Send questions to “Since You Asked,” Mail Tribune Newsroom, P.O. Box 1108, Medford, OR 97501; or by email to firstname.lastname@example.org.